Jump to content

jm25

Member
  • Posts

    92
  • Joined

  • Last visited

Everything posted by jm25

  1. Will you share what those two stocks are?
  2. Not being selfish and spreading it to the community and potentially harming / killing those at risk. I also know a healthy 30 year old who died... so there's that too. Americans are way too skeptical of their government. Just take the damn vaccine to help yourself out and those around you. Be a good neighbor.
  3. What price levels for PTON? I'm looking at buying some puts as market hedges on some of these tech names.
  4. Great show so far. I'd also recommend ZeroZeroZero (Prime)... similar feel to the movie Sicario. Also, recently added to Netflix: WACO and The Last Dance.
  5. The idea of this thread is to post a few books you've liked and see if someone has a suggestion based on that list for your next book... I've seen it done on TV show lists... I'll start: Red Notice, Shoe Dog, American Kingpin... Looking for my next non-fiction book that captures you like a movie.
  6. 1) Constellation Software 2) Boyd Group Income Fund (Good luck finding a better stock chart...)
  7. Why is the stock been down so much lately?
  8. https://www.theglobeandmail.com/report-on-business/small-business/startups/new-services-allow-you-to-talk-to-a-doctor-from-the-comfort-of-your-living-room/article35783939/
  9. You can buy onlinemed.com from its current owner for the low, low price of C$131,568 on godaddy
  10. See attached (September 2016). JKD_Capital_-_Canadian_Housing.pdf
  11. The website exists. A quick google search of "share hotel room" game me this: http://www.easynest.com/
  12. Posted it here: http://www.cornerofberkshireandfairfax.ca/forum/investment-ideas/rx-biosyent/
  13. Is anyone buying Gazprom or Lukoil? Is the sell off warranted? Does anyone see these events impacting these two large players long-term?
  14. The company minimizes deal competition by focusing on niche products with peak penetration of between $2-15 million which is below the radar of mid and large pharma companies. Biosyent builds its sales and marketing teams around a product. This approach maximizes profit and minimizes costs, as sales teams are put in place only when needed and expand only when the product’s sales can support the expansion. Biosyent has 4 approved products: one in growth phase (FeraMAX), two in launch phase (Cathejell + FeraMAX Powder) and another in pre-launch (women’s health product). The company defines growth phase as minimum 20% growth year over year in product sales. The pipeline has 2 products in regulatory phase that will be launched in Q4 2014 and management is confident it can source 3 more products for 2015 launch. We believe the company will have 9 products on the market by year end 2015. - Great business model (like Paladin Labs). Minimal to no capex, strong growth - Significant growth and margins - Strong balance sheet (no debt) - Strong Management team with large insider ownership http://espacemc.com/en/investment-ideas/biosyent Investor Presentation: https://docs.google.com/viewer?a=v&pid=sites&srcid=ZGVmYXVsdGRvbWFpbnxiaW9zeWVudHxneDoxYjA3MzgzYzdjNDM5NWM5 If there's enough interest we can start up a thread for the Company.
  15. Check out Biosyent (TSXV:RX) - best way to describe it is a mini-Paladin Labs.
  16. What are your views on Biosyent - specifically their product portfolio? Good growth as a mini-Paladin Labs. Strong growth/margins, low capex, etc. I'd like to hear your views.
  17. I agree - royalty trusts / MLPs that are paying out unsustainable dividends that are allowing them to maintain lofty valuations. Becomes expensive to short though with the yield.
  18. Interesting topic. I'm more interested in specific companies though. Provides a good hedge too.
×
×
  • Create New...